Arrow Fat Left Icon Arrow Fat Right Icon Arrow Right Icon Cart Icon Close Circle Icon Expand Arrows Icon Facebook Icon Twitter Icon Youtube Icon Hamburger Icon Information Icon Down Arrow Icon Mail Icon Mini Cart Icon Person Icon Ruler Icon Search Icon Shirt Icon Triangle Icon Bag Icon Play Video
We've Moved! Coding Leader is now Healthcare Training Leader. Visit us at www.HCTrainingLeader.com We've Moved! Coding Leader is now Healthcare Training Leader. Visit us at www.HCTrainingLeader.com
  • CMS Coverage Of Hepatitis B Screening
  • Post author
    Lacy Gaskins

CMS Coverage Of Hepatitis B Screening

The Centers for Medicare & Medicaid Services (CMS) requests that Medicare Administrative Contractors (MACs) work to accommodate CMS coverage of Hepatitis B screening for non-pregnant, high risk individuals with the appropriate U.S. Food and Drug Administration (FDA) approved/cleared laboratory tests. The coverage is compliant with Clinical Laboratory Improvement Act (CLIA) regulations.

Full Transmittal: https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2017Downloads/R3831CP.pdf

Subject: Screening for Hepatitis B Virus (HBV) Infection

Number: 3831

Title: 9859

Release Date: June 29, 2017

Effective Date: September 8, 2016

Implementation Date: October 2, 2017

Special Notes: Transmittal 3804, dated June 29, 2017, is being rescinded and replaced by Transmittal 3831, dated, August 4, 2017 to provide clarification in Pub. 100-04 Business Requirement 9859.04.13 and to revise the note. The new note will read, "Payment for HBV is not separately payable for ESRD facilities (72X TOB) unless reported with Modifier AY." The corresponding update tonote is being made in the Pub. 100-04 claims processing manual. All other information remains the same.

  • Post author
    Lacy Gaskins